awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33567889-E20732F3-FBA6-4942-93A4-4CB2912BE0EC
Q33567889-E20732F3-FBA6-4942-93A4-4CB2912BE0EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33567889-E20732F3-FBA6-4942-93A4-4CB2912BE0EC
Continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as example.
P2860
Q33567889-E20732F3-FBA6-4942-93A4-4CB2912BE0EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33567889-E20732F3-FBA6-4942-93A4-4CB2912BE0EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c4a84aba3e5fda649d169dcb259550660e27d5e
P2860
Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.